Results
74,396 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Pandit SumitaChief Financial Officer |  GGenpact LTDGrant or award | A | — 76.7K sh | Sep 11, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Pandit SumitaChief Financial Officer | GGenpact LTD Grant or award | A | — 76.7K sh | Sep 11, 2026 |
| 9 | North John FDirector |  XPELXPEL, Inc.Option exercise | M | — 441 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Berger DietmarChief Medical Officer |  GILDGILEAD SCIENCES, INC.Option exercise | M | — 533 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Venkatesh VandanaEVP and Chief Legal Officer |  VZVERIZON COMMUNICATIONS INCGrant or award | A | $1,277 90 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise | M | — 8,780 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Olsen Kevin M.Director, President and CEO |  DORMDorman Products, Inc.Option exercise | M | — 11.7K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Mercier JohannaChief Comm & Corp Aff Officer | GILDGILEAD SCIENCES, INC. Option exercise | M | — 2,797 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Dolan John JosephChief Financial Officer |  EHTHeHealth, Inc.Tax withholding | F | $5,390 5,859 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 9 | Olsen Kevin M.Director, President and CEO | DORMDorman Products, Inc. Option exercise | M | — 4,749 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 9 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER |  WGSGeneDx Holdings Corp.Option exercise | M | — 6,547 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Option exercise | M | $76K 4,400 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Bawel David BenjaminSVP & CHIEF ACCOUNTING OFFICER |  DGICADONEGAL GROUP INCOption exercise | M | $120K 8,326 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Mercier JohannaChief Comm & Corp Aff Officer | GILDGILEAD SCIENCES, INC. Tax withholding | F | $195K 1,347 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 8 | Musunuri ShankarDirector, Chief Executive Officer |  OCGNOcugen, Inc.Open-market sale · 10b5-1 plan | SELL | $64K 57.3K sh | Sep 11, 2026 traded Sep 9, 2026 |
| 8 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | $128K 6,600 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale · 10b5-1 plan | SELL | $345K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $280K 520 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $558K 1,040 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $344K 640 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $273K 505 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $273K 512 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 7 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $277K 522 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 6 | Feeley KevinCHIEF FINANCIAL OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 2,462 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 5 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | — 60.7K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 5 | Gracey CraigChief Accounting Officer |  OMDAOmada Health, Inc.Open-market sale · 10b5-1 plan | SELL | $14K 644 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 5 | Malady KyleEVP and Group CEO-VZ Business | VZVERIZON COMMUNICATIONS INC Grant or award | A | $1,738 122 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 5 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | — 59.4K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 5 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | LTHLife Time Group Holdings, Inc. Option exercise | M | — 34.8K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 5 | Mercier JohannaChief Comm & Corp Aff Officer | GILDGILEAD SCIENCES, INC. Option exercise | M | — 2,797 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 5 | O'Day Daniel PatrickDirector, Chairman & CEO | GILDGILEAD SCIENCES, INC. Option exercise | M | — 8,780 sh | Sep 11, 2026 traded Sep 10, 2026 |
| 5 | Stueland KatherineDirector, CHIEF EXECUTIVE OFFICER | WGSGeneDx Holdings Corp. Option exercise | M | — 6,547 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 5 | Rogers George Ted IIIDirector |  GREEVulcan Infrastructure & Power Inc.Derivative conversion | C | — 16.0K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 5 | Rogers George Ted IIIDirector | GREEVulcan Infrastructure & Power Inc. Derivative conversion | C | — 16.0K sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $837K 1,539 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $116K 215 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $212K 396 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $415K 761 sh | Sep 11, 2026 traded Sep 11, 2026 |
| 4 | Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner |  HNGEHinge Health, Inc.Derivative conversion · 10b5-1 plan | C | — 150.0K sh | Sep 11, 2026 traded Sep 10, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $87K 160 sh | Sep 11, 2026 traded Sep 9, 2026 |
| 4 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $69K 131 sh | Sep 11, 2026 traded Sep 9, 2026 |